Table of Contents
Volume 4 | Supplement 2
Publication Date: January 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S39 |
Newer Cytotoxic and Targeted Agents Are Advancing the Treatment of Lung Cancer Chandra P. Belani |
|
Contributions | ||
S40-S44 |
Gemcitabine and Carboplatin Regimens in Advanced Non–Small-Cell Lung Cancer: Focus on Randomized Phase III Trials Martin J. Edelman |
|
S45-S49 |
The Emerging Role of Gemcitabine in Combination with Radiation in Locally Advanced, Unresectable Non–Small-Cell Lung Cancer Corey J. Langer |
|
S50-S55 |
Gemcitabine-Based Combinations as Preoperative Therapy in Resectable Non–Small-Cell Lung Cancer Mark A. Socinski, M. Patricia Rivera, Frank C. Detterbeck |
|
S56-S63 |
New Agents in the Treatment of Small-Cell Lung Cancer: Focus on Gemcitabine Alberto A. Chiappori, Caio M. Rocha-Lima |
|
S64-S67 |
Current Data with Pemetrexed in Non–Small-Cell Lung Cancer Alex A. Adjei |
|
S68-S73 |
Antisense Oligonucleotides in the Treatment of Non–Small-Cell Lung Cancer Angela M. Davies, David R. Gandara, Primo N. Lara, Jr., Philip C. Mack, Derick H.M. Lau, Paul H. Gumerlock |
|